12 December 2016 - Pediapharm is very pleased to announce Health Canada's approval of Otixal (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution for the treatment of acute otitis media with tympanostomy tubes in paediatric patients (aged 6 months and older).

Otixal is the first and only antibiotic and steroid combination ear drop available in single, sterile, preservative-free and unit-dose packaging.

Read Pediapharma press release